BDBM50099747 1-{4-Carbamoyl-2-[2-(4-carbamoyl-2-{4-carboxy-2-[(9,10-dioxo-9,10-dihydro-phenanthrene-3-carbonyl)-amino]-butyrylamino}-butyrylamino)-acetylamino]-butyryl}-pyrrolidine-2-carboxylic acid::CHEMBL48506
SMILES NC(=O)CCC(NC(=O)C(CCC(O)=O)NC(=O)c1ccc2C(=O)C(=O)c3ccccc3-c2c1)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O
InChI Key InChIKey=WLIWRCAKUDRJTP-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50099747
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair